Until recently, the Unmethlyated, long CGG repeat track in the FMR1 5' UTR was thought to have little or no phenotype consequence. Now, it is well established that this expanded repeat track leads to an increased risk for premature ovarian failure (POP) among women who carry the premutation (55-199 repeats) and an increased risk for a late-onset tremor/ataxia syndrome (FXTAS), primarily among men with the premutation. We hypothesize that the high repeat tract in the FMR1 gene increases the risk for these age-related disorders through a dominant negative toxic effect of the FMR1 transcript. The goal of this study is to identify the full phenotypic spectrum of the high repeat track alleles of the FMR1 gene among adult carriers and to elucidate the risk factors associated with phenotype expression. In previous grant period, we established an infrastructure to identify individuals from the general population and from families with fragile X syndrome (FXS) who carry high repeat alleles. Our results suggest that the increased risk is primarily associated with premutation allele carriers. Thus, in this re-submission, we will focus on ascertaining all first-degree relatives of premutation carriers-all subjects will be ascertained in a systematic manner to reduce the bias in estimates of relative risk and penetrance among repeat size groups. We will test the hypothesis that the FMR1 repeat length is a QTL that influences an individual's pattern of relative strengths and weaknesses within their neuropsychological functioning, but is generally not associated with clinical problems. We will also test the hypothesis that there are age-dependent, presymptomatic signs related to FXTAS that can be identified among premutation carriers. We will establish quantitative parameters that can be tracked over time to examine the natural history of FXTAS and determine if other health factors are associated with onset, progression and severity of symptoms. These studies will begin to unravel one aspect of the complex pathways related to neuropsychological function and age-associated neurological and cognitive decline. ? ?

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD029909-11
Application #
7105618
Study Section
Epidemiology of Clinical Disorders and Aging Study Section (ECDA)
Program Officer
Urv, Tiina K
Project Start
1994-05-05
Project End
2010-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
11
Fiscal Year
2006
Total Cost
$865,555
Indirect Cost
Name
Emory University
Department
Genetics
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Nolin, Sarah L; Sah, Sachin; Glicksman, Anne et al. (2013) Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 161A:771-8
Hunter, Jessica Ezzell; Sherman, Stephanie; Grigsby, Jim et al. (2012) Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology 26:156-64
Hunter, Jessica Ezzell; Leslie, Mary; Novak, Gloria et al. (2012) Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet 159B:549-59
Juncos, Jorge L; Lazarus, Joash T; Rohr, Julia et al. (2012) Olfactory dysfunction in fragile X tremor ataxia syndrome. Mov Disord 27:1556-9
Hunter, Jessica Ezzell; Epstein, Michael P; Tinker, Stuart W et al. (2012) The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet 42:415-22
Visootsak, Jeannie; Charen, Krista; Rohr, Julia et al. (2012) Diagnosis of fragile X syndrome: a qualitative study of African American families. J Genet Couns 21:845-53
Spath, Marian A; Feuth, Ton B; Smits, Arie P T et al. (2011) Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med 13:643-50
Chang, Martin C; DeCaro, John J; Zheng, Mei et al. (2011) Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology 59:1018-23
Allen, Emily Graves; Hunter, Jessica E; Rusin, Michele et al. (2011) Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology 25:404-411
Spath, M A; Feuth, T B; Allen, E G et al. (2011) Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod 26:2185-91

Showing the most recent 10 out of 41 publications